Contact
Please use this form to send email to PR contact of this press release:
NeoMatrix Therapeutics (NMT) Peptide Discovery Advances Treatment of Burn Injury - Novel Peptide Progresses to Phase 2
TO:
Neomatrix Therapeutics
Neomatrix Therrapewutics, Inc
+1 631-241-4964